Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

ClinicalTrials.gov ID: NCT03631732

Public ClinicalTrials.gov record NCT03631732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 12:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy of switching from a regimen of 2 nucleos(t)Ide reverse transcriptase inhibitors (NRTIs) and a third agent to a fixed dose combination (FDC) of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) versus continuing their baseline regimen in HIV-1 infected, virologically suppressed African American participants.

Study identification

NCT ID
NCT03631732
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
496 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 28, 2018 (Actual)
Primary completion
Aug 12, 2019 (Actual)
Completion
Aug 19, 2020 (Actual)
Last update posted
Sep 5, 2021

2018 – 2020

United States locations

U.S. sites
82
U.S. states
24
U.S. cities
56
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Alabama Medical Group, PC Mobile Alabama 36608 —
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 —
Ruane Clinical Research Group Inc. Los Angeles California 90036 —
Mills Clinical Research Los Angeles California 90069 —
Highland Hospital- Alameda Health System Oakland California 94602 —
Kaiser Permanente Oakland California 94611 —
One Community Health Sacramento California 95811 —
Kaiser Permanente Sacramento California 95825 —
Kaiser Permanente, Department of Infectious Diseases San Leandro California 94577 —
Whitman-Walker Health Washington D.C. District of Columbia 20005 —
Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Dupont Circle Physician's Group Washington D.C. District of Columbia 20009 —
Washington Health Institute Washington D.C. District of Columbia 20017 —
Capital Medical Associates, PC Washington D.C. District of Columbia 20036 —
The GW Medical Faculty Associates Washington D.C. District of Columbia 20037 —
Midland Florida Clinical Research Center, LLC DeLand Florida 32720 —
Therafirst Medical Center Fort Lauderdale Florida 33308 —
Gary J. Richmond, M.D., P.A. Fort Lauderdale Florida 33316 —
Midway Immunology and Research Center Ft. Pierce Florida 34982 —
AHF- The Kinder Medical Group Miami Florida 33133 —
University of Miami School of Medicine Division of Infectious Disease Miami Florida 33136 —
AIDS Healthcare Foundation - South Beach Miami Beach Florida 33140 —
Orlando Immunology Center Orlando Florida 32803-1851 —
St. Joseph's Hospital Comprehensive Research Institute Tampa Florida 33614 —
AIDS Research & Treatment Center of the Treasure Coast Vero Beach Florida 32960 —
Triple O Research Institute, P.A. West Palm Beach Florida 33407 —
Emory Hospital Midtown Infectious Disease Clinic Atlanta Georgia 30308 —
Atlanta ID Group, PC Atlanta Georgia 30309 —
Augusta University Medical Center Augusta Georgia 30912 —
Infectious Disease Specialist of Atlanta Decatur Georgia 30033 —
Mercer University, Department of Internal Medicine Macon Georgia 31201 —
Chatham County Health Department Savannah Georgia 31401 —
Howard Brown Health Center Chicago Illinois 60613 —
NorthStar Medical Center Chicago Illinois 60657 —
Indiana CTSI Clinical Research Center Indianapolis Indiana 46077 —
University Medical Center- New Orleans (UMCNO) New Orleans Louisiana 70112 —
SLVHCS Building J, 7th floor, Outpatient Infectious Disease Clinic New Orleans Louisiana 70119 —
CrescentCare Health New Orleans Louisiana 70130 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston University Medical Center Boston Massachusetts 02118 —
Claudia T. Martorell, MD, LLC d/b/a The Research Institute Springfield Massachusetts 01105 —
Be Well Medical Center Berkley Michigan 48072 —
Wayne State University- Integrative Bioscience Center Detroit Michigan 48201 —
Henry Ford Hospital Detroit Michigan 48202 —
St. John Newland Medical Associates Southfield Michigan 48075 —
Hennepin County Medical Center, Positive Care Clinic Minneapolis Minnesota 55414 —
G.V. 'Sonny' Montgomery VAMC Jackson Mississippi 39216 —
Southampton Clinical Research St Louis Missouri 63108 —
Clinical: Saint Louis University, New Hope Clinic St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Southampton Healthcare, Inc. St Louis Missouri 63139 —
Huntridge Family Clinic Las Vegas Nevada 89104 —
Prime Healthcare Services- St. Michael's LLC d/b/a Saint Michael's Medical Center Newark New Jersey 07102 —
North Shore University Hospital/Division of Infectious Diseases Manhasset New York 11030 —
Jacobi Medical Center The Bronx New York 10461 —
Montefiore Medical Center The Bronx New York 10467 —
NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 —
UT Physicians Charlotte North Carolina 28207 —
Duke University Health System Durham North Carolina 27710 —
East Carolina University, The Brody School of Medicine, ECU Adult Specialty Care Greenville North Carolina 27834 —
Rosedale Infectious Diseases Huntersville North Carolina 28078 —
AHF Pensacola North Carolina 32504 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
University of Cincinnati College of Medicine Cincinnati Ohio 45267 —
MetroHealth Medical Center Cleveland Ohio 44109 —
Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19066 —
Philadelphia FIGHT Community Health Centers Philadelphia Pennsylvania 19107 —
Palmetto Health Richland Columbia South Carolina 29203 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Central Texas Clinical Research Austin Texas 78705 —
St. Hope Foundation Bellaire Texas 77401 —
AIDS Arms, Inc. DBA Prism Health North Texas Dallas Texas 75208 —
North Texas Infectious Diseases Consultants, P.A. Dallas Texas 75246 —
Tarrant County Infectious Disease Associates Fort Worth Texas 76104 —
Therapeutic Concepts, PA Houston Texas 77004 —
Thomas Street Health Center Houston Texas 77030 —
Research Access Network Houston Texas 77098 —
The Crofoot Research Center, INC (dba Gordon E. Crofoot MD PA) Houston Texas 77098 —
DCOL Center for Clinical Research Longview Texas 75605 —
Community Health Care, Hilltop Medical Clinic Tacoma Washington 98405 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03631732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 5, 2021 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03631732 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →